Zinc salts in dermatology;Sels de zinc en dermatologie

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 5, 2004, Pages 455-460

  Stephan F ^a   Revuz, J ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCONATE ZINC; MINOCYCLINE; PHYTATE; TRACE ELEMENT; ZINC DERIVATIVE; ZINC SULFATE;

ABDOMINAL PAIN; ACNE; ACRODERMATITIS ENTEROPATHICA; ANTIINFLAMMATORY ACTIVITY; ATAXIA; COPPER DEFICIENCY; CYTOKINE PRODUCTION; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EXCRETION; DRUG INDICATION; DRUG MEGADOSE; DRUG TOLERANCE; DRUG USE; FOOD DRUG INTERACTION; HEMATOLOGIC DISEASE; HUMAN; INFLAMMATION; LEISHMANIASIS; LETHARGY; LIVER DISEASE; NAUSEA; NEUROLOGIC DISEASE; REVIEW; SKIN ULCER; TERATOGENESIS; VERRUCA VULGARIS; VOMITING;

EID: 17344381215     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93639-3     Document Type: Review

References (57)

1. Prasad A. Clinical and biolochemical spectrum of zinc deficiency in human subjects. In: Clinical, Biochemical and Nutritional Aspects of Trace Elements. 1982; Alan R. Liss Inc NY:3-62.
2. Sainte-Marie I, Jumbou O, Tenaud I, Dreno B. Comparative study of the in vitro inflammatory activity of three nickel salts on keratinocytes. Acta Derm Venereol 1998;78:169-72.
3. Gueniche A, Viac J, Lizard G, Charveron M, Schmitt D. Protective effect of zinc on keratinocyte activation markers induced by interferon or nickel. Acta Derm Venereol 1995;75:19-23.
4. Dreno B, Trossaert M, Boiteau HL, Litoux P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol 1992;72:250-2.
5. Rostan EF, DeBuys HV, Madey DL, Pinnell SR. Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol 2002;41:606-11.
6. Sugimoto Y, Lopez-Solache I, Labrie F, Luu-The V. Cations inhibit specifically type I 5 alpha-reductase found in human skin. J Invest Dermatol 1995;104:775-8.
7. Stamatiadis D, Bulteau-Portois MC, Mowszowicz I. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol 1988;119:627-32.
8. Bouhanna P, Bakhon D, Mazharian R. Inhibition de l'activité 5 alpha réductasique du zinc potentialisé par la vitamine B6 dans le traitement de l'alopécie androgénétique et rôle de la N-acétyl-cystéine dans l'alopécie chimio-induite. Nouv Dermatol 2000;19:616-8.
9. Murphy JV. Intoxication following ingestion of elemental zinc. JAMA 1970;212:2119-20.
10. Lewis MR, Kokan L. Zinc gluconate: acute ingestion. J Toxicol Clin Toxicol 1998;36:99-101.
11. Barceloux DG. Zinc. J Toxicol Clin Toxicol 1999;37:279-92.
12. Patterson WP, Winkelmann M, Perry MC. Zinc-induced copper deficiency: megamineral sideroblastic anemia. Ann Intern Med 1985;103:385-6.
13. Hoffman HN 2nd, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterology 1988;94:508-12.
14. Forman WB, Sheehan D, Cappelli S, Coffman B. Zinc abuse - an unsuspected cause of sideroblastic anemia. West J Med 1990;152:190-2.
15. Igic PG, Lee E, Harper W, Roach KW. Toxic effects associated with consumption of zinc. Mayo Clin Proc 2002;77:713-6.
16. Salzman MB, Smith EM, Koo C. Excessive oral zinc supplementation. J Pediatr Hematol Oncol 2002;24:582-4.
17. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998;132:264-78.
18. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA 1984;252:1443-6.
19. Bonham M, O'Connor J, Coulter J, Alexander D, Downer CS, Hannigan BM et al. Zinc supplementation followed by copper supplementation has no effect on indices of immune function and cooper status in humans. J Trace Elem Exp Med 2001;14:279.
20. Mc Amena L, Bonham M, O'Connor JM, Walsh P, Downes CS, Hannigan BM et al. Putative markers of cooper status and lipoprotein metabolism are unaffected by chronic zinc supplementation at the upper in take level. J Trace Elem Exp Med 2001;14:285.
21. Ketcheson MR, Barron GP, Cox DH. Relationship of maternal dietary zinc during gestation and lactation to development and zinc, iron and copper content of the postnatal rat. J Nutr 1969;98:303-11.
22. Osendarp SJ, van Raaij JM, Arifeen SE, Wahed M, Baqui AH, Fuchs GJ. A randomized, placebo-controlled trial of the effect of zinc supplementation during pregnancy on pregnancy outcome in Bangladeshi urban poor. Am J Clin Nutr 2000;71:114-9.
23. Simmer K, Lort-Phillips L, James C, Thompson RP. A double-blind trial of zinc supplementation in pregnancy. Eur J Clin Nutr 1991;45:139-44.
24. Kannan S, Dick R, Johnson V, Brewer JG. Effect of zinc concentration in breast milk. J Trace Elem Exp Med 2001;14:285.
25. August D, Janghorbani M, Young VR. Determination of zinc and copper absorption at three dietary Zn-Cu ratios by using stable isotope methods in young adult and elderly subjects. Am J Clin Nutr 1989;50:1457-63.
26. Cragg RA, Christie GR, Phillips SR, Russi RM, Kury S, Mathers JC et al. A novel zinc-regulated human zinc transporter, hZTL1, is localized to the enterocyte apical membrane. J Biol Chem 2002;277:22789-97.
27. DiSilvestro RA, Cousins RJ. Physiological ligands for copper and zinc. Annu Rev Nutr 1983;3:261-88.
28. Richards MP, Cousins RJ. Mammalian zinc homeostasis: requirement for RNA and metallothionein synthesis. Biochem Biophys Res Commun 1975;64:1215-23.
29. Calesnick B, Dinan AM. Zinc deficiency and zinc toxicity. Am Fam Physician 1988;37:267-70.
30. Michaelson G, Juhlin L, Vahlquist A. Serum zinc and retinol binding protein in acne. Br J Dermatol 1977;96:283-6.
31. Dreno B, Stalder JF, Pecquet C, Boiteau HL, Barriere H. Variations in cutaneous zinc concentrations after oral administration of zinc gluconate. Acta Derm Venereol 1984;64:341-4.
32. Dreno B, Vandermeeren MA, Rigou V. Le zinc et la peau. Ann Dermatol Venereol 1988;115:741-6.
33. Moynahan EJ, Barnes PM. Zinc deficiency and a synthetic diet for lactose intolerance. Lancet 1973;1:676-7.
34. Kury S, Dreno B, Bezieau S, Giraudet S, Kharfi M, Kamoun R et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002;31:239-40.
35. Nakano A, Nakano H, Nomura K, Toyomaki Y, Hanada K. Novel SLC39A4 mutations in acrodermatitis enteropathica. J Invest Dermatol 2003;120:963-6.
36. Michaelsson G. Zinc therapy in acrodermatitis enteropathica. Acta Derm Venereol 1974;54:377-81.
37. Michaelsson G, Juhlin L, Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977;113:31-6.
38. Goransson K, Liden S, Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol 1978;58:443-8.
39. Hillstrom L, Pettersson L, Hellbe L, Kjellin A, Leczinsky CG, Nordwall C. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol 1977;97:681-4.
40. Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol 1980;60:337-40.
41. Weissman K, Wadskov S, Sondergaard J. Oral zinc sulfate therapy for acne vulgaris. Acta Dermatol Venereol 1977;57:357-60.
42. Orris L, Shalita AR, Sibulkin D, London SJ, Gans EH. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol 1978;114:1018-20.
43. Dreno B, Amblard P, Agache P, Sirot S, Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol 1989;69:541-3.
44. Cunliffe WJ, Burke B, Dodman B, Gould DJ. A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris. Br J Dermatol 1979;101:321-5.
45. Michaelsson G, Juhlin L, Ljunghall K. A double-blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 1977;97:561-6.
46. Revuz J, Amblard P, Dréno B, Lorette G, Ortonne JP, Puissant A. Efficacité du gluconate de zinc dans le traitement de l'acné inflammatoire. Abst Dermatol 1990;77:40-2.
47. Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C). Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001;203:135-40.
48. Najim RA, Sharquie KE, Farjou IB. Zinc sulphate in the treatment of cutaneous leishmaniasis: an in vitro and animal study. Mem Inst Oswaldo Cruz 1998;93:831-7.
49. Sharquie KE, Najim RA, Farjou IB, Al-Timimi DJ. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001;26:21-6.
50. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 2002;146:423-31.
51. Houston S, Haggard J, Williford J Jr, Meserve L, Shewokis P. Adverse effects of large-dose zinc supplementation in an institutionalized older population with pressure ulcers. J Am Geriatr Soc 2001;49:1130-2.
52. Wilkinson EA, Hawke CI. Does oral zinc aid the healing of chronic leg ulcers? A systematic literature review. Arch Dermatol 1998;134:1556-60.
53. Haeger K, Lanner E. Oral zinc sulphate and ischaemic leg ulcers. Vasa 1974;3:77-81.
54. Phillips A, Davidson M, Greaves MW. Venous leg ulceration: evaluation of zinc treatment, serum zinc and rate of healing. Clin Exp Dermatol 1977;2:395-9.
55. Greaves MW, Ive FA. Double-blind trial of zinc sulphate in the treatment of chronic venous leg ulceration. Br J Dermatol 1972;87:632-4.
56. Hallbook T, Lanner E. Serum-zinc and healing of venous leg ulcers. Lancet 1972;2:780-2.
57. Perafan-Riveros C, Franca LF, Alves AC, Sanches JA Jr. Acrodermatitis enteropathica: case report and review of the literature. Pediatr Dermatol 2002;19:426-31.